Cargando…
Refractory epilepsy and nonadherence to drug treatment
In patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional and intentional nonadherence among Norwegian patients with refractory epilep...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885656/ https://www.ncbi.nlm.nih.gov/pubmed/31819918 http://dx.doi.org/10.1002/epi4.12367 |
_version_ | 1783474764094898176 |
---|---|
author | Henning, Oliver Lossius, Morten I. Lima, Maren Mevåg, Morten Villagran, Antonia Nakken, Karl O. Johannessen Landmark, Cecilie |
author_facet | Henning, Oliver Lossius, Morten I. Lima, Maren Mevåg, Morten Villagran, Antonia Nakken, Karl O. Johannessen Landmark, Cecilie |
author_sort | Henning, Oliver |
collection | PubMed |
description | In patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional and intentional nonadherence among Norwegian patients with refractory epilepsy and try to identify possible risk factors. At the National Centre for Epilepsy in Norway, 333 consecutive adult in‐ and outpatients with refractory epilepsy participated in an anonymous survey about adherence to drug treatment. Twenty‐two percentages admitted that they sometimes or often forgot to take their drugs as scheduled, and 19% reported that they, rarely, sometimes or often intentionally did not follow the AED treatment plan agreed upon with their physician. Young age and depression were significantly correlated with unintentional nonadherence. Intentional nonadherence was associated with young age (36 years or younger). We found nonadherence not to be associated with any specific AED. In conclusion, about one‐fifth of patients with refractory epilepsy admitted that they did not adhere to the agreed drug treatment plan, either intentionally or unintentionally. Measures to reduce nonadherence in this patient group may improve seizure control and should be tailored to address both unintentional and intentional lack of adherence. |
format | Online Article Text |
id | pubmed-6885656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68856562019-12-09 Refractory epilepsy and nonadherence to drug treatment Henning, Oliver Lossius, Morten I. Lima, Maren Mevåg, Morten Villagran, Antonia Nakken, Karl O. Johannessen Landmark, Cecilie Epilepsia Open Short Research Article In patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional and intentional nonadherence among Norwegian patients with refractory epilepsy and try to identify possible risk factors. At the National Centre for Epilepsy in Norway, 333 consecutive adult in‐ and outpatients with refractory epilepsy participated in an anonymous survey about adherence to drug treatment. Twenty‐two percentages admitted that they sometimes or often forgot to take their drugs as scheduled, and 19% reported that they, rarely, sometimes or often intentionally did not follow the AED treatment plan agreed upon with their physician. Young age and depression were significantly correlated with unintentional nonadherence. Intentional nonadherence was associated with young age (36 years or younger). We found nonadherence not to be associated with any specific AED. In conclusion, about one‐fifth of patients with refractory epilepsy admitted that they did not adhere to the agreed drug treatment plan, either intentionally or unintentionally. Measures to reduce nonadherence in this patient group may improve seizure control and should be tailored to address both unintentional and intentional lack of adherence. John Wiley and Sons Inc. 2019-11-06 /pmc/articles/PMC6885656/ /pubmed/31819918 http://dx.doi.org/10.1002/epi4.12367 Text en © 2019 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Short Research Article Henning, Oliver Lossius, Morten I. Lima, Maren Mevåg, Morten Villagran, Antonia Nakken, Karl O. Johannessen Landmark, Cecilie Refractory epilepsy and nonadherence to drug treatment |
title | Refractory epilepsy and nonadherence to drug treatment |
title_full | Refractory epilepsy and nonadherence to drug treatment |
title_fullStr | Refractory epilepsy and nonadherence to drug treatment |
title_full_unstemmed | Refractory epilepsy and nonadherence to drug treatment |
title_short | Refractory epilepsy and nonadherence to drug treatment |
title_sort | refractory epilepsy and nonadherence to drug treatment |
topic | Short Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885656/ https://www.ncbi.nlm.nih.gov/pubmed/31819918 http://dx.doi.org/10.1002/epi4.12367 |
work_keys_str_mv | AT henningoliver refractoryepilepsyandnonadherencetodrugtreatment AT lossiusmorteni refractoryepilepsyandnonadherencetodrugtreatment AT limamaren refractoryepilepsyandnonadherencetodrugtreatment AT mevagmorten refractoryepilepsyandnonadherencetodrugtreatment AT villagranantonia refractoryepilepsyandnonadherencetodrugtreatment AT nakkenkarlo refractoryepilepsyandnonadherencetodrugtreatment AT johannessenlandmarkcecilie refractoryepilepsyandnonadherencetodrugtreatment |